FDA inspection
Ropack, Inc. (Site A & B): FDA inspection ending Jun 17, 2022
FDA inspection 1173334 · No Action Indicated (NAI) · Anjou
Key facts
| Inspection ID | 1173334 |
|---|---|
| Firm | Ropack, Inc. (Site A & B) |
| FEI number | 3002674295 |
| Address | 10801 Mirabeau St |
| City | Anjou |
| Country | Canada |
| Fiscal year | 2022 |
| Inspection end date | Jun 17, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data